Banca de DEFESA: RENATO DANTAS DE MEDEIROS

Uma banca de DEFESA de DOUTORADO foi cadastrada pelo programa.
STUDENT : RENATO DANTAS DE MEDEIROS
DATE: 26/09/2024
TIME: 14:00
LOCAL: Videoconferência
TITLE:

Desenvolvimento de um hidrogel termorresponsivo contendo o extrato das cascas do caule de Commiphora leptophloeos com potencial aplicação no tratamento de candidíase vulvovaginal


KEY WORDS:

Burseraceae; imburana; tannins; fungal infections; herbal medicine;


PAGES: 67
BIG AREA: Ciências da Saúde
AREA: Farmácia
SUMMARY:

Commiphora leptophloeos (Mart.) J.B. Gillett. (Burseraceae) is a medicinal plant native from Caatinga biome. It is popularly used for treating gynecological infections. The present work aimed to characterize the chromatographic profile and marker content of the C. leptophloeos stem bark extract, and to evaluate its toxicity and antifungal and antibiofilm potential against Candida spp., through pre-clinical tests in vitro and in vivo. The study also aimed to develop a thermoresponsive hydrogel containing C. leptophloeos extract. The extract (4%) was loaded into a hydrogel formulation based on chitosan (1.0%) and poloxamer 407 (18%), and their physical (organoleptic characteristics, rheological tests and texture profile analysis), chemical (proanthocyanidin content and pH) and microbiological parameters were evaluated. Under the conditions of the study, the extract and hydrogel showed good physicochemical and microbiological stability for 3 months at 25 °C ± 2 °C and 60% ± 5% relative humidity (RH). In addition, the phytochemical analyses carried out by liquid chromatography and mass spectrometry and by chemical tests enabled the annotation and quantification of the total proanthocyanidin content in the extract (230.38 mg/g of extract) and per gram of hydrogel (135.23 mg of proanthocyanidin/g of hydrogel). Additionally, the hydrogel had an appearance, colour and odour characteristic of the extract, a pH close to 4.5, compatible with the vaginal environment, and a sol-gel transition temperature close to body temperature (35 °C). The toxicity of the extract and hydrogel were assessed in vitro by the haemolytic activity and cytotoxicity tests on uterine/endometrial epithelial cells (HEC-1A), and in vivo by the acute toxicity test on the alternative Galleria mellonella model. In all tests, the free extract and the hydrogel formulation proved to be biocompatible, since they did not cause cytotoxicity in human erythrocytes and HEC-1A cells, and no signs of acute toxicity and mortality were observed in G. mellonella larvae. In vitro antifungal and antibiofilm efficacy was evaluated against reference strains of Candida spp. and clinical isolates (including fluconazole-resistant strains) obtained from blood cultures of patients with candidaemia and vaginal secretions of patients with vulvovaginal candidiasis. The minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) were determined using the microdilution technique, and biofilm inhibition was assessed using the crystal violet and XTT assays. The synergistic effect of the extract in combination with fluconazole was determined using the checkerboard method. The extract showed antifungal activity with MIC values ranging from 2,500 to 312.5 μg/mL and significantly reduced the biofilm formed on all the Candida spp. strains investigated. Furthermore, the combined action of the extract with fluconazole produced synergistic antifungal effects against Candida spp. (IFIC=0.31-1.5). In the sequence, the antifungal potential of the free extract and hydrogel were evaluated in vivo in the alternative model of C. albicans infection in G. mellonella. The hydrogel containing the extract showed greater antifungal potential than the free extract at all concentrations tested, and in the survival assay showed high larval viability in larvae infected with C. albicans. In general, the findings of this work revealed that the antifungal and antibiofilm effect of C. leptophloeos extract was enhanced when incorporated into the hydrogel and toxicity was reduced. Finally, it can be concluded that the C. leptophloeos extract has a potential antifungal effect and can be applied as an active ingredient in the development of a phytotherapeutics for treating fungal infections. 


COMMITTEE MEMBERS:
Externo à Instituição - RODRIGO LUIZ FABRI - UFJF
Externo à Instituição - DOUGLAS SIQUEIRA DE ALMEIDA CHAVES - UFRRJ
Externo à Instituição - ANA CAROLINA BARBOSA PADOVAN - UNIFAL-MG
Interno - 1639820 - ARNOBIO ANTONIO DA SILVA JUNIOR
Presidente - 1490222 - SILVANA MARIA ZUCOLOTTO LANGASSNER
Notícia cadastrada em: 19/09/2023 10:28
SIGAA | Superintendência de Tecnologia da Informação - (84) 3342 2210 | Copyright © 2006-2024 - UFRN - sigaa04-producao.info.ufrn.br.sigaa04-producao